A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : BAL / bioartificial liver

[Related PubMed/MEDLINE]
Total Number of Papers: 214
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   BAL  (>> Co-occurring Abbreviation)
Long Form:   bioartificial liver
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Efficient Generation of an Fah/Rag2 Dual-Gene Knockout Porcine Cell Line Using CRISPR/Cas9 and Adenovirus. FAH, Rag2
2019 Fabrication and invitro evaluation of a packed-bed bioreactor based on an optimum two-stage culture strategy. FBS, FC, hiHeps, PB
2019 Hemocompatibility improvement of decellularized spleen matrix for constructing transplantable bioartificial liver. DSM
2019 The role of cellular interactions in the induction of hepatocyte polarity and functional maturation in stem cell-derived hepatic cells. ECM, hPSCs
2018 Advanced In Vitro HepaRG Culture Systems for Xenobiotic Metabolism and Toxicity Characterization. ---
2018 Challenges on the road to a multicellular bioartificial liver. ---
2018 Experimental bio-artificial liver: Importance of the architectural design on ammonia detoxification performance. BC, LDH, LMOs, NRS
2018 Functional hepatocyte clusters on bioactive blend silk matrices towards generating bioartificial liver constructs. ---
2018 Functionally coated polyethersulfone hollow fiber membranes: A substrate for enhanced HepG2/C3A functions. Gel, GTA, HFM
10  2018 Hydrophilic ZIF-8 decorated GO nanosheets improve biocompatibility and separation performance of polyethersulfone hollow fiber membranes: A potential membrane material for bioartificial liver application. HFMs, ZGs, ZIF-8
11  2017 Advances in methods for characterization of hepatic urea cycle enzymatic activity in HepaRG cells using UPLC-MS/MS. ASL, CPS I, OTC, UC
12  2017 Alpha-1 antichymotrypsin is involved in astrocyte injury in concert with arginine-vasopressin during the development of acute hepatic encephalopathy. ACT, ALF, AVP, EC, HE
13  2017 Clinical translation of bioartificial liver support systems with human pluripotent stem cell-derived hepatic cells. hPSCs
14  2017 Concise Review: Liver Regenerative Medicine: From Hepatocyte Transplantation to Bioartificial Livers and Bioengineered Grafts. HLCs
15  2017 Functional Evaluation of a Bioartificial Liver Support System Using Immobilized Hepatocyte Spheroids in a Porcine Model of Acute Liver Failure. ALF
16  2017 Generation of carbamoyl phosphate synthetase 1 reporter cell lines for the assessment of ammonia metabolism. CPS1, HLCs
17  2017 Optimizing the fluidized bed bioreactor as an external bioartificial liver. ---
18  2016 Improved survival of porcine acute liver failure by a bioartificial liver device implanted with induced human functional hepatocytes. ALF, hiHep-BAL, hiHeps
19  2016 Performance of cold-preserved rat liver Microorgans as the biological component of a simplified prototype model of bioartificial liver. LDH, LMOs
20  2015 A non-adhesive hybrid scaffold from gelatin and gum Arabic as packed bed matrix for hepatocyte perfusion culture. ---
21  2015 Blood-Compatible Polymer for Hepatocyte Culture with High Hepatocyte-Specific Functions toward Bioartificial Liver Development. PMEA, PTHFA, YAP
22  2015 Development and validation of a bioartificial liver device with fluidized bed bioreactors hosting alginate-encapsulated hepatocyte spheroids. ---
23  2015 Development of a bioreactor based on magnetically stabilized fluidized bed for bioartificial liver. MSFBs
24  2015 Selectivity of biopolymer membranes using HepG2 cells. CA, NC, PC, PP, PTFE, PVDF
25  2014 Potential and Challenges of Induced Pluripotent Stem Cells in Liver Diseases Treatment. ESCs, hiPSCs, HLCs, iPSCs
26  2013 Effect of oxygen concentration on viability and metabolism in a fluidized-bed bioartificial liver using P and C NMR spectroscopy. NTP
27  2013 Evaluation of polypropylene hollow-fiber prototype bioreactor for bioartificial liver. ---
28  2013 Increased hepatic functionality of the human hepatoma cell line HepaRG cultured in the AMC bioreactor. ---
29  2013 Long-term culture and coculture of primary rat and human hepatocytes. ---
30  2013 Newly established human liver cell line: a potential cell source for the bioartificial liver in the future. hALR
31  2013 Novel in vitro and mathematical models for the prediction of chemical toxicity. ADRs
32  2012 Advances in cell sources of hepatocytes for bioartificial liver. OLT
33  2012 Artificial liver support system reduces intracranial pressure more effectively than bioartificial system: an experimental study. ALF, CPP, ELS, FPSA, ICP
34  2012 Controlled formation of heterotypic hepatic micro-organoids in anisotropic hydrogel microfibers for long-term preservation of liver-specific functions. ---
35  2012 Effect of fulminant hepatic failure porcine plasma supplemented with essential components on encapsulated rat hepatocyte spheroids. ---
36  2012 Evaluation of a novel hybrid bioartificial liver based on a multi-layer flat-plate bioreactor. HBAL, NBAL, PERV, PT, RT
37  2012 Factors influencing the transfer of porcine endogenous retroviruses across the membrane in bioartificial livers. PERVs, RT
38  2012 Hepatocyte function within a stacked double sandwich culture plate cylindrical bioreactor for bioartificial liver system. ---
39  2012 Immunosafety evaluation of a multilayer flat-plate bioartificial liver. ---
40  2012 Key challenges to the development of extracorporeal bioartificial liver support systems. ---
41  2012 Microbiological safety of a novel bio-artificial liver support system based on porcine hepatocytes: a experimental study. PBMCs, PERVs, RT
42  2012 New advances in MR-compatible bioartificial liver. ---
43  2012 Potentiality of immobilized pig hepatocyte spheroids in bioartificial liver system. FHF
44  2012 Systematic review: extracorporeal bio-artificial liver-support system for liver failure. OLT
45  2012 The effect of rat acute-liver-failure plasma on HepaRG cells. ALF, DMSO
46  2012 The influence of membrane molecular weight cutoff on a novel bioartificial liver. ---
47  2012 Three dimensional cultures of rat liver cells using a natural self-assembling nanoscaffold in a clinically relevant bioreactor for bioartificial liver construction. GOT, GPT, LDH, SAPN
48  2012 [New evidence of porcine endogenous retrovirus transmission with new bio-artificial liver system: a experimental study]. PBMCs, PCR, PERV, RT
49  2011 Bioartificial liver devices: Perspectives on the state of the art. ---
50  2011 Bioartificial liver system based on choanoid fluidized bed bioreactor improve the survival time of fulminant hepatic failure pigs. FHF
51  2011 Differential function of protective agents at each stage of the hypothermic preservation of hepatocytes. Mat
52  2011 Diffusion-mediated in situ alginate encapsulation of cell spheroids using microscale concave well and nanoporous membrane. PDMS
53  2011 Effects of membrane molecular weight cutoff on performance of a novel bioartificial liver. ---
54  2011 Gas-permeable membranes and co-culture with fibroblasts enable high-density hepatocyte culture as multilayered liver tissues. PDMS
55  2011 Improved preclinical safety assessment using micro-BAL devices: the potential impact on human discovery and drug attrition. ---
56  2011 Perfusion of 3D encapsulated hepatocytes--a synergistic effect enhancing long-term functionality in bioreactors. ---
57  2011 Preparation and characterization of chitosan porous microcarriers for hepatocyte culture. CPMs
58  2010 Challenging small human hepatocytes with opiates: further characterization of a novel prototype bioartificial liver. SH, UDP
59  2010 Long-term absence of porcine endogenous retrovirus infection in chronically immunosuppressed patients after treatment with the porcine cell-based Academic Medical Center bioartificial liver. AMC-BAL, HCWs, PBMCs, PERVs
60  2010 Roles of spheroid formation of hepatocytes in liver tissue engineering. ---
61  2010 Stable overexpression of pregnane X receptor in HepG2 cells increases its potential for bioartificial liver application. CYP3A, PXR
62  2010 Three-dimensional perfusion cultures of mouse and pig fetal liver cells in a packed-bed reactor: effect of medium flow rate on cell numbers and hepatic functions. FLCs
63  2009 Engineering analysis and development of the spheroid reservoir bioartificial liver. SRBAL
64  2009 In vitro evaluation of a multi-layer radial-flow bioreactor based on galactosylated chitosan nanofiber scaffolds. OCR, RBCs
65  2009 Introduction of a novel prototype bioartificial liver support system utilizing small human hepatocytes in rotary culture. SH
66  2009 Life support of artificial liver: development of a bioartificial liver to treat liver failure. ---
67  2009 Optimization of mass transfer for toxin removal and immunoprotection of hepatocytes in a bioartificial liver. ---
68  2009 Porcine endogenous retrovirus released by a bioartificial liver infects primary human cells. hHEP, PERV, RT-PCR
69  2009 Preservation of porcine hepatocytes in three-dimensional bioreactor at room temperature using epigallocatechin-3-gallate. EGCG
70  2009 Stimulating effects of fibroblast growth factors on hepatic function of fetal liver cells synergistically with oncostatin M in three-dimensional culture. FLCs, OSM
71  2009 Transport advances in disposable bioreactors for liver tissue engineering. ALF, TE
72  2008 Ammonia metabolism capacity of HepG2 cells with high expression of human glutamine synthetase. AFP-TRE, hGS
73  2008 Evaluation of a new immortalized human fetal liver cell line (cBAL111) for application in bioartificial liver. GS, PPH
74  2008 Hepatic reconstruction from fetal porcine liver cells using a radial flow bioreactor. Cx, HGF, RFB
75  2008 High-throughput nuclear magnetic resonance metabolomic footprinting for tissue engineering. HTP, NMR
76  2008 Peritoneal implantation of cryopreserved encapsulated porcine hepatocytes in rats without immunosuppression: viability and function. ---
77  2008 Radial flow hepatocyte bioreactor using stacked microfabricated grooved substrates. ---
78  2007 A bioartificial liver device secreting interleukin-1 receptor antagonist for the treatment of hepatic failure in rats. AdIL-1Ra, FHF, GalN, IL-1
79  2007 Characteristic gene expression induced by polyurethane foam/spheroid culture of hepatoma cell line, Hep G2 as a promising cell source for bioartificial liver. PUF
80  2007 Extracorporeal bioartificial liver using the radial-flow bioreactor in treatment of fatal experimental hepatic encephalopathy. ---
81  2007 Functional and morphological comparison of three primary liver cell types cultured in the AMC bioartificial liver. AMC, FHHs, MHHs, MPHs
82  2007 Hybrid braided 3-D scaffold for bioartificial liver assist devices. PET
83  2007 In vitro comparison of two bioartificial liver support systems: MELS CellModule and AMC-BAL. AMC-BAL, MELS
84  2007 Integrated energy and flux balance based multiobjective framework for large-scale metabolic networks. EBA, FBA, NC
85  2007 Oxygen uptake rates and liver-specific functions of hepatocyte and 3T3 fibroblast co-cultures. OUR
86  2007 Significant contribution of liver nonparenchymal cells to metabolism of ammonia and lactate and cocultivation augments the functions of a bioartificial liver. ALF, HN-BAL, NPCs
87  2007 Time-related analysis of metabolic liver functions, cellular morphology, and gene expression of hepatocytes cultured in the bioartificial liver of the Academic Medical Center in Amsterdam (AMC-BAL). mRNA
88  2006 Alginate/galactosylated chitosan/heparin scaffold as a new synthetic extracellular matrix for hepatocytes. AL, ECM, GC, GJIC
89  2006 Bioartificial liver: its pros and cons. ALF
90  2006 Comparison between bioartificial and artificial liver for the treatment of acute liver failure in pigs. AAA, CHDF, FHF, NT, PE
91  2006 Differentiation of human embryonic stem cells to hepatocytes using deleted variant of HGF and poly-amino-urethane-coated nonwoven polytetrafluoroethylene fabric. dHGF, DMSO, hES, PAU, PTFE
92  2006 Enhanced liver functions of hepatocytes cocultured with NIH 3T3 in the alginate/galactosylated chitosan scaffold. AL, ECM, GC, GJIC
93  2006 Evaluation of a bioartificial liver based on a nonwoven fabric bioreactor with porcine hepatocytes in pigs. FHF
94  2006 Functional evaluation of a new bioartificial liver system in vitro and in vitro. ALB, ALF, TB
95  2006 Hepatocyte and kupffer cells co-cultured on micropatterned surfaces to optimize hepatocyte function. ---
96  2006 Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes. ES
97  2006 Subnormothermic preservation maintains viability and function in a porcine hepatocyte culture model simulating bioreactor transport. ALF, UW, WE
98  2006 The significant improvement of survival times and pathological parameters by bioartificial liver with recombinant HepG2 in porcine liver failure model. GS
99  2006 Treatment of fulminant hepatic failure in rats using a bioartificial liver device containing porcine hepatocytes producing interleukin-1 receptor antagonist. AdIL-1Ra, FHF, GalN, IL-1
100  2006 [Design of a hollow-fiber bioreactor and perfusion study in vitro]. ---